Molecules, Vol. 25, Pages 1188: Development and Characterization of the Shortest Anti-Adhesion Peptide Analogue of B49Mod1

Molecules, Vol. 25, Pages 1188: Development and Characterization of the Shortest Anti-Adhesion Peptide Analogue of B49Mod1 Molecules doi: 10.3390/molecules25051188 Authors: Yuan Lyu Wadie D. Mahauad-Fernandez Chioma M. Okeoma Inhibition of cancer cell adhesion is an effective approach to killing adherent cancer cells. B49 and its analog B49Mod1 peptides, derived from the extracellular domain (ECD) of bone marrow stromal antigen 2 (BST-2), display anti-adhesion activity on breast cancer cells. However, the minimal sequence required for this anti-adhesion activity is unknown. Here, we further characterized the anti-adhesion activity of B49Mod1. We show that the anti-adhesion activity of B49Mod1 may require cysteine-linked disulfide bond and that the peptide is susceptible to proteolytic deactivation. Using structure-activity relationship studies, we identified an 18-Mer sequence (B18) as the minimal peptide sequence mediating the anti-adhesion activity of B49Mod1. Atomistic molecular dynamic (MD) simulations reveal that B18 forms a stable complex with the ECD of BST-2 in aqueous solution. MD simulations further reveal that B18 may cause membrane defects that facilitates peptide translocation across the bilayer. Placement of four B18 chains as a transmembrane bundle results in water channel formation, indicating that B18 may impair membrane integrity and form pores. We hereby identify B18 as the minimal peptide sequence required for the anti-adhesion activity of B49M...
Source: Molecules - Category: Chemistry Authors: Tags: Article Source Type: research